These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 17785670

  • 1. Up-regulation of hippocampal serotonin metabolism in mild cognitive impairment.
    Truchot L, Costes SN, Zimmer L, Laurent B, Le Bars D, Thomas-Antérion C, Croisile B, Mercier B, Hermier M, Vighetto A, Krolak-Salmon P.
    Neurology; 2007 Sep 04; 69(10):1012-7. PubMed ID: 17785670
    [Abstract] [Full Text] [Related]

  • 2. A distinct [18F]MPPF PET profile in amnestic mild cognitive impairment compared to mild Alzheimer's disease.
    Truchot L, Costes N, Zimmer L, Laurent B, Le Bars D, Thomas-Antérion C, Mercier B, Hermier M, Vighetto A, Krolak-Salmon P.
    Neuroimage; 2008 Apr 15; 40(3):1251-6. PubMed ID: 18313943
    [Abstract] [Full Text] [Related]

  • 3. Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease.
    Anchisi D, Borroni B, Franceschi M, Kerrouche N, Kalbe E, Beuthien-Beumann B, Cappa S, Lenz O, Ludecke S, Marcone A, Mielke R, Ortelli P, Padovani A, Pelati O, Pupi A, Scarpini E, Weisenbach S, Herholz K, Salmon E, Holthoff V, Sorbi S, Fazio F, Perani D.
    Arch Neurol; 2005 Nov 15; 62(11):1728-33. PubMed ID: 16286547
    [Abstract] [Full Text] [Related]

  • 4. Differential association of [11C]PIB and [18F]FDDNP binding with cognitive impairment.
    Tolboom N, van der Flier WM, Yaqub M, Koene T, Boellaard R, Windhorst AD, Scheltens P, Lammertsma AA, van Berckel BN.
    Neurology; 2009 Dec 15; 73(24):2079-85. PubMed ID: 20018636
    [Abstract] [Full Text] [Related]

  • 5. Differences in hippocampal metabolism between amnestic and non-amnestic MCI subjects: automated FDG-PET image analysis.
    Clerici F, Del Sole A, Chiti A, Maggiore L, Lecchi M, Pomati S, Mosconi L, Lucignani G, Mariani C.
    Q J Nucl Med Mol Imaging; 2009 Dec 15; 53(6):646-57. PubMed ID: 20016455
    [Abstract] [Full Text] [Related]

  • 6. Differential hypometabolism patterns according to mild cognitive impairment subtypes.
    Jauhiainen AM, Kangasmaa T, Rusanen M, Niskanen E, Tervo S, Kivipelto M, Vanninen RL, Kuikka JT, Soininen H.
    Dement Geriatr Cogn Disord; 2008 Dec 15; 26(6):490-8. PubMed ID: 18987469
    [Abstract] [Full Text] [Related]

  • 7. Longitudinal study of amnesic patients at high risk for Alzheimer's disease: clinical, neuropsychological and magnetic resonance spectroscopy features.
    Rami L, Gómez-Anson B, Sanchez-Valle R, Bosch B, Monte GC, Lladó A, Molinuevo JL.
    Dement Geriatr Cogn Disord; 2007 Dec 15; 24(5):402-10. PubMed ID: 17934274
    [Abstract] [Full Text] [Related]

  • 8. Impairment of episodic and semantic autobiographical memory in patients with mild cognitive impairment and early Alzheimer's disease.
    Leyhe T, Müller S, Milian M, Eschweiler GW, Saur R.
    Neuropsychologia; 2009 Oct 15; 47(12):2464-9. PubMed ID: 19409401
    [Abstract] [Full Text] [Related]

  • 9. Reduced 5-HT2A receptor binding in patients with mild cognitive impairment.
    Hasselbalch SG, Madsen K, Svarer C, Pinborg LH, Holm S, Paulson OB, Waldemar G, Knudsen GM.
    Neurobiol Aging; 2008 Dec 15; 29(12):1830-8. PubMed ID: 17544547
    [Abstract] [Full Text] [Related]

  • 10. Abnormal white matter independent of hippocampal atrophy in amnestic type mild cognitive impairment.
    Bai F, Zhang Z, Watson DR, Yu H, Shi Y, Yuan Y.
    Neurosci Lett; 2009 Sep 22; 462(2):147-51. PubMed ID: 19596405
    [Abstract] [Full Text] [Related]

  • 11. Impaired visual recognition memory in amnestic mild cognitive impairment is associated with mesiotemporal metabolic changes on magnetic resonance spectroscopic imaging.
    Didic M, Ranjeva JP, Barbeau E, Confort-Gouny S, Fur YL, Felician O, Mancini J, Poncet M, Ceccaldi M, Cozzone P.
    J Alzheimers Dis; 2010 Sep 22; 22(4):1269-79. PubMed ID: 20930281
    [Abstract] [Full Text] [Related]

  • 12. Balance features in Alzheimer's disease and amnestic mild cognitive impairment.
    Leandri M, Cammisuli S, Cammarata S, Baratto L, Campbell J, Simonini M, Tabaton M.
    J Alzheimers Dis; 2009 Sep 22; 16(1):113-20. PubMed ID: 19158427
    [Abstract] [Full Text] [Related]

  • 13. Absolute quantification in proton magnetic resonance spectroscopy is useful to differentiate amnesic mild cognitive impairment from Alzheimer's disease and healthy aging.
    Watanabe T, Shiino A, Akiguchi I.
    Dement Geriatr Cogn Disord; 2010 Sep 22; 30(1):71-7. PubMed ID: 20689286
    [Abstract] [Full Text] [Related]

  • 14. Noradrenergic denervation facilitates the release of acetylcholine and serotonin in the hippocampus: towards a mechanism underlying upregulations described in MCI patients?
    Jackisch R, Gansser S, Cassel JC.
    Exp Neurol; 2008 Oct 22; 213(2):345-53. PubMed ID: 18625224
    [Abstract] [Full Text] [Related]

  • 15. Absent gender differences of hippocampal atrophy in amnestic type mild cognitive impairment.
    Bai F, Zhang Z, Watson DR, Yu H, Shi Y, Zhu W, Wang L, Yuan Y, Qian Y.
    Neurosci Lett; 2009 Jan 30; 450(2):85-9. PubMed ID: 19071194
    [Abstract] [Full Text] [Related]

  • 16. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
    Wang Z, Zhao C, Yu L, Zhou W, Li K.
    Acta Radiol; 2009 Apr 30; 50(3):312-9. PubMed ID: 19235582
    [Abstract] [Full Text] [Related]

  • 17. Bioavailable testosterone is associated with a reduced risk of amnestic mild cognitive impairment in older men.
    Chu LW, Tam S, Lee PW, Wong RL, Yik PY, Tsui W, Song Y, Cheung BM, Morley JE, Lam KS.
    Clin Endocrinol (Oxf); 2008 Apr 30; 68(4):589-98. PubMed ID: 17973937
    [Abstract] [Full Text] [Related]

  • 18. A multicenter (1)H-MRS study of the medial temporal lobe in AD and MCI.
    Jessen F, Gür O, Block W, Ende G, Frölich L, Hammen T, Wiltfang J, Kucinski T, Jahn H, Heun R, Maier W, Kölsch H, Kornhuber J, Träber F.
    Neurology; 2009 May 19; 72(20):1735-40. PubMed ID: 19451528
    [Abstract] [Full Text] [Related]

  • 19. [Discriminatory validity and association of the mini-mental test (MMSE) and the memory alteration test (M@T) with a neuropsychological battery in patients with amnestic mild cognitive impairment and Alzheimer's disease].
    Rami L, Bosch B, Valls-Pedret C, Caprile C, Sánchez-Valle Díaz R, Molinuevo JL.
    Rev Neurol; 2009 May 19; 49(4):169-74. PubMed ID: 19621317
    [Abstract] [Full Text] [Related]

  • 20. Changes in central 5-HT(1A) receptor binding in mesial temporal epilepsy measured by positron emission tomography with [(11)C]WAY100635.
    Ito S, Suhara T, Ito H, Yasuno F, Ichimiya T, Takano A, Maehara T, Matsuura M, Okubo Y.
    Epilepsy Res; 2007 Jan 19; 73(1):111-8. PubMed ID: 17097271
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.